Search for Clinical Trial Results

Sponsored By

Anaplastic Large Cell Lymphoma - 61 Studies Found

Status Study
Completed Study Name: A Treatment-Option Protocol to Provide Brentuximab Vedotin to Eligible Patients Completing Studies SGN35-005 or C25001
Condition:
  • Disease, Hodgkin
  • Lymphoma, Large-Cell, Anaplastic
  • Lymphoma
    Date: 2010-09-03
    Interventions: Drug: brentuximab vedotin Every 21 days by intravenous infusion (1.8 mg/kg)
Completed Study Name: Combination Chemotherapy in Treating Children With Lymphoma
Condition: Lymphoma
Date: 1999-11-01
Interventions:
  • Biological: filgrastim Other N
Completed Study Name: A Study Of Oral PF-02341066, A C-Met/Hepatocyte Growth Factor Tyrosine Kinase Inhibitor, In Patients With Advanced Cancer
Condition:
  • Non-Small Cell Lung Cancer (ALK-positive)
  • Non-Small Cell Lung Cancer (c-Met Dependent)

    • Date: 2007-12-29
    Interventions:
    • Drug: PF-02341066 Escalating d
Recruiting Study Name: Romidepsin and Lenalidomide in Treating Patients With Previously Untreated Peripheral T-Cell Lymphoma
Condition:
  • Adult Nasal Type Extranodal NK/T-cell Lymphoma
  • Anaplastic Large Cell L
    Date: 2014-09-03
    Interventions:
    • Drug: romidepsin Given IV
Terminated Study Name: Oral Clofarabine for Relapsed/Refractory Non-Hodgkin Lymphoma
Condition:
  • Follicular Lymphoma
  • Marginal Zone Lymphoma
  • Mantle Cell Lym
    Date: 2008-03-24
    Interventions: Drug: Clofarabine Taken orally once a day (in the AM) on days 1 through 21 of a 28-day cycle for a maxim
Terminated Study Name: Bortezomib, Doxorubicin Hydrochloride Liposome, and Rituximab in Treating Patients With Diffuse Large B-Cell Lymphoma That Has Relapsed or Not Responded to Treatment
Condition: Lymphoma
Date: 2009-02-25
Interventions:
  • Biological: rituximab Given IV
Terminated Study Name: Yttrium Y 90 Ibritumomab Tiuxetan and Rituximab in Treating Patients With Relapsed or Refractory Diffuse Large B-Cell Non-Hodgkin's Lymphoma
Condition: Lymphoma
Date: 2003-12-10
Interventions:
  • Biological: rituximab
  • Drug: cytarabine
Completed Study Name: Rituximab and Combination Chemotherapy in Treating Patients With Relapsed or Refractory Large Cell Lymphoma
Condition: Lymphoma
Date: 2000-05-02
Interventions:
  • Biological: filgrastim
  • Biological: rituxim
Completed Study Name: CAR T Cells Targeting CD30 Positive Lymphomas (4SCAR30273)
Condition: Lymphomas
Date: 2014-10-22
Interventions: Genetic: Anti-CD30 CAR T cells Autologous 4th generation withdrawal lentiviral-transduced anti-CD30 CAR
Completed Study Name: Combination Chemotherapy in Treating Patients With Relapsed or Refractory Intermediate-Grade or High-Grade Non-Hodgkin's Lymphoma
Condition: Lymphoma
Date: 2000-08-03
Interventions:
  • Drug: doxorubicin hydrochloride
  • Drug: topo
<<< Previous | Next >>>